WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022

Aug 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-08-01

Reporting Person: Abraham Silji (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-01	Common Stock	S	5374.00	$343.9349	Disposed	3201.2997	Direct

Footnotes

F1: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $343.69 to $344.10, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.